Annovis Bio Inc
Biotechnology
Healthcare
ANVS
19.49 M shares
NYSE MKT US
traded
23 Sep 2025
listed
no
open
2.29
52 week high
9.87
high
2.32
52 week low
0.00
low
2.22
growth
-73.67 %
previous Close
2.32
P/E ratio
market cap
53.98 M
div yield
0
usd
Jun 2025
qoq
revenue
0.00 %
net incoming
-6.22 B
-112.00 %
eps
0.00 %
0.00 %
eps surprise
20.62 %
net profit margin
-622005800000.00 %
0.00 %
operating incoming
0.00 %
net change in cash
-5.11 B
-143.70 %
cash on hand
17.13 B
76.00 %
cost of revenue
0.00 %
top top